2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought

2/21/2026Hansoh Pharma’s Ameile Wins EU Approval for EGFR-Mutant Lung Cancer

2/20/2026CSPC's Long-Acting SYH2082 Clears FDA to Begin Clinical Trials

2/16/2026CSPC's Long-Acting Ropivacaine Injection Cleared for Clinical Trials i...

2/16/2026FindCure Secures CNY 100M+ Series B to Accelerate Cancer Therapy Progr...

2/16/2026CStone's Trispecific Antibody CS2009 Receives FDA IND Clearance, Ente...

2/14/2026Recordati to Withdraw from China After Rare Disease Portfolio Underper...

2/13/2026Shenzhen Immunofoco Biotechnology files Hong Kong IPO application

2/13/2026ProteLight Pharmaceuticals Files Hong Kong IPO application

2/13/2026VivaVision Files Hong Kong IPO to Fund Late-Stage Ophthalmology Progra...

2/13/2026Salubris Files Hong Kong IPO to Expand Cardiovascular-Kidney-Metabolic...

More>>

2/20/2026China Biotech Kicks Off 2026 with $863 Million in January Raises

2/16/2026Long-Acting Obesity Drugs Drive Record January Licensing Boom for Chin...

2/16/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...

2/13/2026China Biotech Dealmaking and Financing Stay Strong in January 2026 Des...

2/12/2026China NMPA Approves Nine New Drugs in January 2026, Expanding Beyond O...

2/12/2026Today's China Crucible: What It Means for Pharma (PharmExec)

2/10/2026China Overhauls Drug Administration Rules, Emphasizing Quality and Cli...

2/10/2026China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse (IBD...

2/5/2026Global Pharma in 2025: China Remains a Key Market Amid Rising Competit...

2/5/2026China Biotech Emerges as Global Deal Powerhouse, Analysts Cite Strong ...

1/29/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...

More>>